10-K Decoder · All companies

Kura Oncology, Inc.

KURA · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$67.5M$53.9M+25.2%
Operating income−$304M−$193M−57.2%
Net income−$279M−$174M−60.2%

Questions

What was Kura Oncology's revenue in FY2025?
$67.5M in FY2025 (Fiscal year ended Dec 31, 2025), +25.2% vs $53.9M a year earlier, per its 10-K filed Mar 2026.
Was Kura Oncology profitable in FY2025?
No: net income was −$279M and operating income −$304M in FY2025.